-
Leicester fairytale turns sour as relegation to third tier looms
-
Pope Leo blasts 'exploitation' as he wrap up tour of resource-rich Angola
-
Varma ton revives Mumbai's IPL hopes with win over Gujarat
-
Formula One makes rule changes after drivers' criticism
-
Singer D4vd charged with murder over teen's body found in Tesla
-
UK PM denies misleading MPs, says officials hid Mandelson info
-
Tit-for-tat blockades once again cripple traffic in Hormuz
-
Cafu says 2026 World Cup is perfect time for Brazil to win again
-
Erdogan vows new measures after deadly Turkey school shootings
-
Rose to take charge at Bournemouth after Iraola exit
-
Olympic status a massive 'boost' for squash says European champion Crouin
-
Kenyan double-double as Korir, Lokedi defend Boston Marathon crowns
-
Whale stranded on German coast swims off, gets stuck again
-
Iran pulling Hormuz 'lever' to maximum in US standoff
-
Argentine film and theater great Luis Brandoni dies at 86
-
French Open sensation Boisson returns to action after 'most difficult' spell
-
Desmond Morris: from 'Naked Ape' to watching 'Big Brother'
-
Rosenior says Chelsea owners supportive despite slump
-
Oil jumps on Hormuz tensions, stocks retreat
-
Romania legend Hagi eyes 'winning every game' on return as coach
-
Rana stars as Bangladesh down New Zealand to level ODI series at 1-1
-
Real Madrid coach Arbeloa launches stout defence of Mbappe
-
Pope Leo blasts 'exploitation' on visit to resource-rich Angola
-
Amy Winehouse's father loses suit against friends selling her clothes
-
Japan issues warning after 7.7-magnitude quake hits north
-
UniCredit woos Commerzbank shareholders in takeover battle
-
European stocks slide as oil jumps on Hormuz tensions
-
Amy Winehouse's dad loses suit against friends for selling clothes
-
Slovenian liberal Golob fails to form government
-
Elon Musk summoned over French X deepfake probe but presence unclear
-
Tsunami warning as major quake hits northern Japan, shakes Tokyo
-
Rana takes 5-32 as Bangladesh bowl out New Zealand for 198
-
Anthropic says will put AI risks 'on the table' with Mythos model
-
Iran says no plan for US peace talks
-
Iran executes two more members of exiled opposition: group
-
Pope Leo visits Angola's diamond-rich northeast
-
US begins 'biggest ever' Philippines war games in thick of Mideast conflict
-
Bulgaria ex-president wins parliamentary majority
-
US begins 'biggest ever' Philippines war games in thick of Mideast war
-
Anxiety lingers in divided Kashmir a year after shooting attack
-
Hit reality show helps rev up Japan's delinquent youth subculture
-
Oil prices bounce back on Iran war escalation
-
Residents return to ravaged homes months after Hong Kong fire
-
Australia's Green wins playoff for third LPGA LA Championship title
-
Pakistan's military chief takes lead on US-Iran talks in diplomatic blitz
-
Thunder, Celtics open NBA playoffs with big wins, Magic shock Pistons
-
US begins Philippines war games in thick of Middle East conflict
-
Who's Bad? Not Michael Jackson in new big-budget biopic
-
Nations gather for first-ever conference on fossil fuel exit
-
Money, lobbyists, inertia: why fossil fuels are so hard to quit
NDT Pharmaceuticals Completes Acquisition of Good Salt(TM) Life, LLC
ATHENS, GA / ACCESS Newswire / September 9, 2025 / NDT Pharmaceuticals Inc. (OTC:NDTP) ("NDTP" or the "Company") today announced that it has completed the acquisition of Good Salt Life, LLC, an Athens, Georgia-based innovator in biosafety and infection control. The transaction closed on Friday, September 5, 2025.
Good Salt Life, a wholly owned subsidiary of NDTP, is a vertically integrated biosafety company that designs, manufactures, and deploys infection control ecosystems combining proprietary hardware, EPA-approved chemistries, and data-driven disinfection protocols. Its solutions serve both animal and human environments across 11 countries and 8 industries, with customers ranging from food producers and hospitals to cruise lines and major sports organizations.
Good Salt Life's brand ecosystem spans consumer pet care, home care, cosmetics, antimicrobial chemistry, and cutting edge chemical delivery technology, including products trusted by leading institutions such as Merck Animal Health, United Airlines, Carnival Cruise Line, Marriott, and the NFL.
"This acquisition marks a transformative moment for NDTP," said Zach O'Shea, President and CEO of NDT Pharmaceuticals. "Good Salt Life's mission of combining sustainability, innovation, and wellness aligns perfectly with our vision for growth. Together, we are building a company that is not only committed to shareholder value but also to creating cleaner, safer, and healthier solutions for everyday life."
Additional details on the transaction and integration plans will be shared in the coming weeks.
About NDT Pharmaceuticals, Inc. (OTC:NDTP)
NDT Pharmaceuticals, Inc. (OTC:NDTP) is a publicly traded company focused on advancing innovative consumer health and wellness solutions. With its recent acquisition of Good Salt Life Inc., NDTP has expanded its strategic direction into sustainable, science-driven products that promote healthier living. The Company is committed to building value through investments in brands that protect people, pets, and the planet while aligning with growing consumer demand for eco-friendly and health-conscious alternatives.
About Good Salt Life, LLC
Good Salt Life, LLC is dedicated to promoting vitality through eco-friendly, nature-derived products that support healthier living environments. With a focus on innovation and sustainability, the company offers safe and effective solutions for home, pet, personal care, and animal health. Through strategic partnerships, including collaborations in the B2B animal health sector, Good Salt Life, LLC continues to drive advancements that benefit both people and animals. For more information, visit www.goodsaltlife.com.
Forward-Looking Statements
This press release contains forward-looking statements, as that term is defined in the Private Litigation Reform Act of 1995, that involve significant risks and uncertainties. Forward-looking statements can be identified through the use of words such as "may," "might," "will," "intend," "should," "could," "can," "would," "continue," "expect," "believe," "anticipate," "estimate," "predict," "outlook," "potential," "plan," "seek," and similar expressions and variations or the negatives of these terms or other comparable terminology. Readers are cautioned not to place undue reliance on these forward-looking statements, which reflect the Company's current expectations and speak only as of the date of this release. Actual results may differ materially from the Company's current expectations. Except as required by law, the Company does not undertake any responsibility to revise or update any forward-looking statements.
Contact:
[email protected]
SOURCE: NDT Pharmaceuticals Inc.
View the original press release on ACCESS Newswire
D.Moore--AMWN